Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02410577
What this trial is testing

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT03367715
What this trial is testing

Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma

Who this might be right for
MGMT-unmethylated Glioblastoma (GBM)GBM
NYU Langone Health 10
Not applicableEnded earlyNCT01954576
What this trial is testing

NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
GlioblastomaBrain Neoplasms
University of Florida 21
Testing effectiveness (Phase 2)Ended earlyNCT04406272
What this trial is testing

VB-111 in Surgically Accessible Recurrent/Progressive GBM

Who this might be right for
GlioblastomaRecurrent Glioblastoma
Dana-Farber Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT02626364
What this trial is testing

Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification

Who this might be right for
Recurrent/Refractory Glioblastoma
Arog Pharmaceuticals, Inc. 11
Early research (Phase 1)WithdrawnNCT04741984
What this trial is testing

Monocyte Antigen Carrier Cells for Newly Diagnosed GBM

Who this might be right for
GlioblastomaGlioma, Malignant
Michael Gunn
Early research (Phase 1)Study completedNCT06095375
What this trial is testing

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Istituto Oncologico Veneto IRCCS 21
Not applicableLooking for participantsNCT07636200
What this trial is testing

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

Who this might be right for
Advanced Solid Tumor CancerStage IV Cancer (Solid Tumors Only)Glioblastoma+2 more
University of Colorado, Boulder 250
Not applicableUnknownNCT03225963
What this trial is testing

Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.

Who this might be right for
Glioblastoma MultiformeAngiogenesis
Taichung Veterans General Hospital 60
Not applicableStudy completedNCT04604158
What this trial is testing

Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

Who this might be right for
CancerCancer MetastaticNeoplasms+20 more
Gillian Gresham 38
Early research (Phase 1)Active Not RecruitingNCT04047706
What this trial is testing

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Northwestern University 18
Testing effectiveness (Phase 2)Study completedNCT01113398
What this trial is testing

AMG 102 and Avastin for Recurrent Malignant Glioma

Who this might be right for
Glioblastoma MultiformeGliosarcoma
Katy Peters 36
Large-scale testing (Phase 3)Study completedNCT00003293
What this trial is testing

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Not applicableStudy completedNCT03075514
What this trial is testing

Ketogenic Diets as an Adjuvant Therapy in Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma, Adult
University of Liverpool 12
Not applicableWithdrawnNCT02194452
What this trial is testing

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

Who this might be right for
Acoustic SchwannomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+92 more
Sue O'Dorisio
Early research (Phase 1)Study completedNCT00612638
What this trial is testing

Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas

Who this might be right for
GlioblastomaGliosarcoma
Duke University 96
Testing effectiveness (Phase 2)UnknownNCT00311857
What this trial is testing

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Who this might be right for
Glioblastoma Multiforme
Heidelberg University 46
Large-scale testing (Phase 3)Ended earlyNCT02414165
What this trial is testing

The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Tocagen Inc. 403
Early research (Phase 1)Ended earlyNCT01902771
What this trial is testing

Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors

Who this might be right for
GliomaBrain CancerBrain Tumor+2 more
Edward Ziga 1
Testing effectiveness (Phase 2)Looking for participantsNCT05664464
What this trial is testing

Glutamate Inhibitors in Glioblastoma

Who this might be right for
Glioblastoma
University of Zurich 120
Next Page